Wednesday
SESSION 32: NEW DEVELOPMENTS IN TREATING CRITICAL LOWER EXTREMITY ISCHEMIA (CLI) IN STENT RESTENOSIS (ISR), ATHERECTOMY AND MORE ON DESs
SESSION 32 SCHEDULE
10:00 AM - 10:05 AM DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: An Interventionalistís View
  Presenter(s):Thomas Zeller, MD  
10:06 AM - 10:11 AM DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: A Surgeonís View
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
10:12 AM - 10:17 AM Pedal Bypass With Deep Vein Arterialization Is Especially Applicable In Certain Specific Critical Ischemic Situations: Late Results
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Abstract      
IN STENT RESTENOSIS (ISR)
10:18 AM - 10:23 AM Insights Into The Pathogenesis Of ISR
  Presenter(s):Renu Virmani, MD  
10:24 AM - 10:29 AM DEBATE: DEBs Are The Best Treatment For ISR
  Presenter(s):Francesco Liistro, MD  
10:30 AM - 10:35 AM DEBATE: Covered Stents (Viabahn) Are The Best Treatment For ISR: Based On The RELINE Randomized Controlled Trial Comparing Them To Balloon PTA
  Presenter(s):Marc Bosiers, MD / Koen Deloose, MD  
10:36 AM - 10:41 AM DEBATE: Atherectomy Or Laser And DEBs Are The Best Treatment For ISR: Good Results Are Durable
  Presenter(s):Jos C. van den Berg, MD, PhD  
10:42 AM - 10:47 AM Optimal Treatment Of ISR: A US Perspective
  Presenter(s):Craig M. Walker, MD  
ATHERECTOMY
10:48 AM - 10:53 AM DEBATE: Atherectomy Will Not Become First Line Treatment Even Though The New Devices Are Better Than The Old
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
10:54 AM - 10:59 AM DEBATE: Atherectomy Is Effective And Durable Treatment For Lower Extremity Occlusive Disease: Which Device Is Best
  Presenter(s):James F. McKinsey, MD  
11:00 AM - 11:05 AM Atherectomy Has Value In Association With DEBs For Fem-Pop Lesions: What Is The Value Of Cilostazol In Preventing Restenosis
  Presenter(s):Thomas Zeller, MD  
11:06 AM - 11:11 AM What Is The Future For Atherectomy After Past Failures And Conflicting Data
  Presenter(s):Sean P. Lyden, MD  
11:12 AM - 11:17 AM Atherectomy Is Of Little Value For Tibial Lesions
  Presenter(s):Jean M. Panneton, MD  
MORE ON DRUG ELUTING STENTS (DES) ETC.
11:18 AM - 11:23 AM DEBATE: New Findings From The ZILVER PTX Trial: Are The Benefits Of This DES Durable: Do The Good Results (3 Years And Beyond) Justify The Costs
  Presenter(s):Michael D. Dake, MD  
11:24 AM - 11:29 AM DEBATE: DEBs And Latest Generation Bare Metal Stents (BMS): Do They Obviate The Need For DESs
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD  
11:30 AM - 11:35 AM What I Learned From European Vascular Specialists About Treating BTK Lesions
  Presenter(s):Peter A. Schneider, MD  
11:36 AM - 11:41 AM Overview Of The Newer And Old CTO Crossing Devices: What Are They And When Are They Useful
  Presenter(s):John H. Rundback, MD, FSIR, FAHA  
11:42 AM - 11:47 AM Decreasing Access Site Complications With Routine Ultrasound Guidance And Micropuncture Technique
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
11:48 AM - 11:59 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break Ė Rhinelander Gallery, 2nd Floor
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 32
previous next